Mozart Therapeutics, Inc.’s Post

View organization page for Mozart Therapeutics, Inc., graphic

2,561 followers

This week marks the 6th Annual Treg-Directed Therapies Summit, held May 21-23 in Boston. We’re honored to have our Chief Scientific Officer, Kristine Swiderek, leading the discussion on the therapeutic potential of modulating CD8 Treg for the treatment of autoimmune disease, including Mozart’s own novel autoimmune checkpoint inhibitor, MTX-101. https://lnkd.in/evaCdwM

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics